Literature DB >> 16374288

Determination of significant parameters for eye injury risk from projectiles.

Stefan M Duma1, Tracy P Ng, Eric A Kennedy, Joel D Stitzel, Ian P Herring, Ferenc Kuhn.   

Abstract

BACKGROUND: Eye injuries affect a large proportion of the population and are expensive to treat. This article presents a parametric analysis of experimental data to determine the most significant factors for predicting ocular injuries or tissue lesions.
METHODS: Using logistic regression, statistical values were generated to determine significant projectile characteristics for predicting ocular injury in published studies. Projectiles included BBs, metal rods, and foam particles with velocities ranging from 2 m/s to 122 m/s.
RESULTS: A normalized energy (energy per projected area) value was found as the best predictor for ocular injury. Using this predictor, a 50% injury risk of corneal abrasion, lens dislocation, hyphema, retinal damage, and globe rupture was found to be 1,503 kg/s(2), 19,194 kg/s(2), 20,188 kg/s(2), 30,351 kg/s(2), and 23,771 kg/s(2), respectively.
CONCLUSION: Normalized energy was the most significant predictor of injury type and tissue lesion. This finding is of great value for history-taking management triaging and as a design aid to minimize the risk of ocular injury for consumer products.

Entities:  

Mesh:

Year:  2005        PMID: 16374288     DOI: 10.1097/01.ta.0000174830.55282.32

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  3 in total

Review 1.  An evaluation of applied biomechanics as an adjunct to systematic specific causation in forensic medicine.

Authors:  Michael D Freeman; Sean S Kohles
Journal:  Wien Med Wochenschr       Date:  2011-07-29

2.  Penetrating eye injury by dart.

Authors:  Tanja Germerott; N Mann; S Axmann
Journal:  Int J Legal Med       Date:  2020-12-17       Impact factor: 2.686

3.  Ocular injury from plastic airsoft bullet through protective steel mesh mask.

Authors:  Yujia Zhou; Esther Osuji; Casey Beal
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.